OFAC publishes North Korea medical-device export blacklist
The U.S. Department of the Treasury's Office of Foreign Assets Control (OFAC) published a list of medical devices that cannot be exported or reexported to North Korea without explicit OFAC authorization, effective June 11, 2026. While a general license permits export of certain agricultural commodities, medicines, and medical devices to North Korea, the devices on this blacklist fall outside that permission and require case-by-case approval. Exporters and freight forwarders shipping medical equipment must screen against this list before shipping to North Korea.
Photo: Los Muertos Crew / Pexels# OFAC Publishes North Korea Medical-Device Export Blacklist
On June 11, 2026, the U.S. Department of the Treasury's Office of Foreign Assets Control (OFAC) issued guidance establishing a list of medical devices subject to specific authorization requirements for export or reexport to North Korea.
Background and Scope
The Department of the Treasury's Office of Foreign Assets Control (OFAC) is publishing a list of medical devices that may not be exported or reexported to North Korea pursuant to the general license authorizing the exportation or reexportation to North Korea of certain agricultural commodities, medicine, medical devices, and replacement parts and components.
While OFAC maintains a general license permitting shipments of certain medical items and agricultural goods to North Korea under humanitarian and trade exceptions, this list carves out specific medical devices that do not qualify for that blanket permission.
Export Requirements
Any exporter or reexporter seeking to send a device appearing on OFAC's blacklist to North Korea must obtain explicit authorization from OFAC before shipment. Without such authorization, the transaction violates U.S. sanctions regulations under the International Emergency Economic Powers Act (IEEPA). This requirement applies to all parties in the supply chain—manufacturers, distributors, freight forwarders, and traders.
The regulation affects exporters across all sectors that handle medical devices, including manufacturers, logistics providers, and trading companies. Even indirect reexports (e.g., a device shipped to a third country and later diverted to North Korea) fall under OFAC's jurisdiction if the U.S. person or entity knows or has reason to know the final destination is North Korea.
What this means for shippers
All exporters and freight forwarders must screen medical-device shipments against OFAC's updated blacklist before accepting cargo destined for North Korea. Failure to obtain specific authorization for listed devices triggers civil penalties up to $250,000 per violation and potential criminal prosecution. Cross-check your product catalog and customer manifests now; do not ship any device on the list without OFAC approval in hand. Review the full blacklist and submit Form OMB 1505-0164 (License Application) to OFAC if uncertain.
